Skip to main content
Premium Trial:

Request an Annual Quote

Frank Williams

Frank Williams, cofounder and CEO of value-based care management company Evolent Health, has been named to the board of directors of precision oncology technology vendor Syapse. Syapse said that Williams, a former CEO of the Advisory Board Company, will be able to offer strategic advice as the company expands its reach. Since late November, Syapse has raised $30 million in new investment, hired a new VP of oncology, entered into a partnership with Roche, and entered the Asian market

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.